October 2013
MPR - Nurse Practitioners' Edition;Fall2013, Vol. 20 Issue 3, p150
The article lists several drugs for mucoskelton disorder which include aleve from Bayer Consumer, arava from Sanofi Aventis SA and athrotec 50 from Pfizer Inc.


Related Articles

  • Stability indicating HPLC method for simultaneous determination of methocarbamol and nimesulide from tablet matrix. Manmode, R. S.; Dhamankar, A. K.; Manwar, J. V.; Laddha, S. S. // Der Chemica Sinica;2011, Vol. 2 Issue 4, p81 

    A reverse phase HPLC method has been developed for simultaneous estimation of methocarbamol and nimesulide in a tablet formulation. The separation was achieved by using Supelcosil LC-8 (4.6 mm I.D x 250 mm) column and methanol, water (60, 40 v/v) as an eluent, at flow rate of 1.0 mL/min....

  • Topical NSAIDs provide effective relief of acute musculoskeletal pain compared to placebo, with no increase in risk of adverse effects. Buchbinder, Rachelle // Evidence Based Medicine;Dec2010, Vol. 15 Issue 6, p177 

    A review is presented of the article "Topical NSAIDs for Acute Pain in Adults" by T. Massey et al., which appeared in a 2010 issue of the "Cochrane Database of Systematic Reviews".

  • MUSCULOSKELETAL DISORDERS.  // MPR - Physician Assistants' Edition;Fall2013, Vol. 20 Issue 3, p150 

    The article offers information on several drugs for the treatment of patients with musculoskeletal disorders. It states that aleve from Bayer Consumer contains 220mg of naproxen sodium for the treatment of minor arthritic pain. It mentions that ansaid from Pfizer contains 50 and 100 mg tablet of...

  • What is the most effective treatment for acute low back pain? Harwood, Marc I.; Sang-ick Chang // Journal of Family Practice;Feb2002, Vol. 51 Issue 2, p118 

    The article discusses the most effective treatment for acute low back pain. Although nonsteroidal anti-inflammatory drugs (NSAID) are more effective that placebo for pain relief in patients with acute low back pain, no consistent evidence show that NSAID are more effective than acetaminophen....

  • 12 MUSCULOSKELETAL DISORDERS.  // Nurse Practitioners Prescribing Reference;Fall2010, Vol. 17 Issue 3, p192 

    The article offers information on various drugs used to treat musculoskeletal disorders such as arthritis, gout, and muscle spasms. The indication and adverse reactions of the muscle relaxant Robaxin from UCB Pharma Inc., the immunosuppressant Imuran from Prometheus Laboratories Inc., and the...

  • SECTION 12: MUSCULOSKELETAL DISORDERS.  // Monthly Prescribing Reference;Oct2010, Vol. 26 Issue 10, p212 

    The article offers information on various drugs used in managing musculoskeletal disorders such as arthritis, gout, and bone disorders. Indications and adverse reactions of the muscle relaxant Amrix from Cephalon Inc., the nonsteroidal antiinflammatory drug (NSAID) Motrin Tablets from Pfizer...

  • Diagnosis and Treatment of Temporomandibular Disorders. GAUER, ROBERT L.; SEMIDEY, MICHAEL J. // American Family Physician;3/15/2015, Vol. 91 Issue 6, p378 

    Temporomandibular disorders (TMD) are a heterogeneous group of musculoskeletal and neuromuscular conditions involving the temporomandibular joint complex, and surrounding musculature and osseous components. TMD affects up to 15% of adults, with a peak incidence at 20 to 40 years of age. TMD is...

  • Safety precautions with NSAIDs. Morris, David // GP: General Practitioner;1/21/2002, p65 

    Focuses on the safety precautions regarding the use of nonsteroidal anti-inflammatory agents (NSAID). Efficacy of NSAID in the treatment of inflammatory musculoskeletal conditions; Availability of ibuprofen over the counter; Precautions on the use of NSAID in patients with history of peptic...

  • Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice. Moore, R. Andrew; Derry, Sheena; Phillips, Ceri J.; McQuay, Henry J. // BMC Musculoskeletal Disorders;2006, Vol. 7, p79 

    Background: Gastrointestinal harm, known to occur with NSAIDs, is thought to be lower with NSAID and gastroprotective agent, and with inhibitors selective to cyclooxygenase-2 (coxibs) at usual plasma concentrations. We examine competing strategies for available evidence of reduced...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics